Metoprolol Succinate Extended-Release Tablets recalled over manufacturing violations

Recall date

April 22, 2015

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

Wockhardt Usa Inc. recalls Metoprolol Succinate Extended-Release Tablets, USP, 100 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-0736-0…

Recall number

D-1270-2015

FDA classification

Class II

Brand / firm

Wockhardt Usa Inc.

Sold / distributed

U.S. Nationwide including Puerto Rico.

Why it was recalled

CGMP Deviations: Firm did not adequately investigate customer complaints.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Metoprolol Succinate Extended-Release Tablets, USP, 100 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-0736-02), B) 500 Count Bottles (NDC: 64679-0736-03), and C) 12 x 30 Tablet Dispenser Pack Cartons (NDC: 64679-0736-09), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC, 20 Waterview Blvd. Parsippany, NJ 07054 USA .